Epidemiological Burden and Hospitalization Trends of Human Metapneumovirus in Spain (2016-2023): A Retrospective Study [0.03%]
西班牙(2016-2023年)人副流感病毒的流行病学负担和住院趋势：一项回顾性研究
Oscar Brochado-Kith,Ruth Gil-Prieto,Angel Gil-de-Miguel
Oscar Brochado-Kith
Introduction: The hospitalization burden of human metapneumovirus (HMPV) in Spain was estimated assessing disease manifestations and risk factors to guide future vaccine strategies. ...
Reimagining Phage Therapy for MDR Pathogens: From Biobanks to Health System Integration-A Review [0.03%]
噬菌体治疗多重耐药病原菌的再思考：从生物库到卫生系统集成-综述文章
Abay A Ayele,Wenfeng Liu,Minfeng Xiao et al.
Abay A Ayele et al.
Multidrug-resistant (MDR) pathogens, exemplified by Klebsiella pneumoniae, pose a critical and escalating threat in low- and middle-income countries (LMICs), where limited diagnostic and therapeutic options exacerbate mortality. Bacteriopha...
Mitigating Vaccine Disparities Through Faith-Based Intervention: A Pre-Post Analysis of Recombinant Zoster Vaccine Knowledge and Acceptance in Socially Vulnerable Racial and Ethnic Minoritized Communities [0.03%]
基于信仰的干预措施缓解疫苗不平等：社会脆弱的少数民族社区带状疱疹重组疫苗知识和接受度的事前事后分析
Jacinda C Abdul-Mutakabbir,Raheem Abdul-Mutakabbir,Samuel J Casey
Jacinda C Abdul-Mutakabbir
Introduction: The incidence of herpes zoster (HZ) is increasing globally. Despite the availability of a highly effective recombinant zoster vaccine (RZV), vaccination rates are still low in the United States, especially a...
Oritavancin in Complicated Bloodstream Infections and Endocarditis in Spain and Italy (ORIBAC Study): A Retrospective Multicenter Observational Study [0.03%]
西班牙和意大利复杂血流感染和心内膜炎中奥利万星的使用（ORIBAC研究）：一项多中心回顾性观察性研究
Antonio Vena,Laura Mezzogori,Matteo Bassetti et al.
Antonio Vena et al.
Introduction: The management of complicated Gram-positive bloodstream infections (cBSI) and infective endocarditis (IE) often requires prolonged intravenous therapy. Transition to oral therapy is frequently unfeasible bec...
Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study [0.03%]
用于预防美国婴儿呼吸道合胞病毒下呼吸道疾病的不同单克隆抗体的疗效及成本效益分析：基于模型的研究
Benjamin Yarnoff,Matthieu Beuvelet,Samira Soudani et al.
Benjamin Yarnoff et al.
Introduction: Respiratory syncytial virus (RSV) is the leading cause of infant hospitalizations in the United States, with a significant seasonal impact on healthcare resources. Long-acting monoclonal antibodies (mAbs), n...
Publisher Correction: Predictive Utility of the Pediatric-EQUAL Scale in Pediatric Candidemia Admitted to PICU Association with Clinical and Microbiological Factors Related Mortality [0.03%]
出版更正：儿科-EQUAL评分对儿科念珠菌血症入住PICU的预测效用与临床和微生物学因素相关的死亡率关联性研究
Muhterem Duyu,Ayşe Aşık
Muhterem Duyu
Published Erratum
Infectious diseases and therapy. 2026 Feb 26. DOI:10.1007/s40121-026-01318-3 2026
Preparing for Tuberculosis Vaccine M72/AS01E Implementation: A Global Demand Forecast and Key Influential Factors [0.03%]
M72/AS01E结核疫苗实施准备工作的全球需求预测及关键影响因素分析研究报告
Judith Kallenberg,Dominique Milea,Thomas Breuer et al.
Judith Kallenberg et al.
Introduction: Tuberculosis (TB) affects over 10 million people worldwide annually, is difficult to treat, and is a major cause of death. The M72/AS01E candidate vaccine is the first vaccine in over 100 years with the pote...
Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in China [0.03%]
Yun-Feng Shi,Lin-Hang Ju,Kang-Ning Wang et al.
Yun-Feng Shi et al.
Introduction: This phase IV study aimed to evaluate the safety of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals aged 2 years and older through active and passive surveillance. ...
Early Antibiotic Therapy in Sepsis Without Shock: A Multimethod Study of Heterogeneous Treatment Effects in ICU Patients [0.03%]
ICU中未发生休克的严重感染患者早期应用抗生素治疗效果的多方法研究
Peng Zhang,Tongkun Zuo,Xingxing Zhu et al.
Peng Zhang et al.
Introduction: The survival benefit of early antibiotic administration in septic shock is well established. In contrast, for sepsis without shock, the current Surviving Sepsis Campaign (SSC) guidelines recommend initiating...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19 [0.03%]
基于中和抗体滴度建立免疫桥梁预测单克隆抗体预防COVID-19有效性的免疫相关保护模型的统计方法
Ilker Yalcin,Leijun Hu,Brandyn West et al.
Ilker Yalcin et al.
Introduction: Neutralizing antibody titers are recognized as an acceptable surrogate efficacy endpoint for immunobridging next-generation monoclonal antibodies (mAbs) to those with demonstrated clinical efficacy for the p...